相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer
Theresa E. Hickey et al.
NATURE MEDICINE (2021)
Storage Conditions and Immunoreactivity of Breast Cancer Subtyping Markers in Tissue Microarray Sections
Angela R. Omilian et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2020)
Bicalutamide Plus Aromatase Inhibitor in Patients with Estrogen Receptor-Positive/Androgen Receptor-Positive Advanced Breast Cancer
Qianyi Lu et al.
ONCOLOGIST (2020)
Prognostic Significance of Androgen Receptor Expression in Triple Negative Breast Cancer: A Systematic Review and Meta-Analysis
Meng Xu et al.
CLINICAL BREAST CANCER (2020)
TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer
Brian D. Lehmann et al.
CLINICAL CANCER RESEARCH (2020)
The age of paraffin block influences biomarker levels in archival breast cancer samples
Hong Chen et al.
ONCOLOGY LETTERS (2020)
AR/ER Ratio Correlates with Expression of Proliferation Markers and with Distinct Subset of Breast Tumors
Nelson Rangel et al.
CELLS (2020)
Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
Sindhu Govindan et al.
BMC CANCER (2020)
A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast Cancer
Ian Krop et al.
CLINICAL CANCER RESEARCH (2020)
Androgen Receptor in Breast Cancer: From Bench to Bedside
Mengyao Chen et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Role of androgen receptor expression in early stage ER+/PgR-/HER2-breast cancer
Barbara Tagliaferri et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Breast cancer
Nadia Harbeck et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Androgen receptor gene expression in primary breast cancer
Neelima Vidula et al.
NPJ BREAST CANCER (2019)
The Dilemma of HER2 Double-equivocal Breast Carcinomas Genomic Profiling and Implications for Treatment
Caterina Marchio et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome
Carmela Ricciardelli et al.
CLINICAL CANCER RESEARCH (2018)
The role of the AR/ER ratio in ER-positive breast cancer patients
Nelson Rangel et al.
ENDOCRINE-RELATED CANCER (2018)
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer
Tiffany A. Traina et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The prognostic value of androgen receptors in breast cancer subtypes
Maria Ryssdal Kraby et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data
Ivana Bozovic-Spasojevic et al.
CLINICAL CANCER RESEARCH (2017)
Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer
Yuka Asano et al.
CANCERS (2017)
The West German Study Group Breast Cancer Intrinsic Subtype study: a prospective multicenter decision impact study utilizing the Prosigna assay for adjuvant treatment decision-making in estrogen-receptor-positive, HER2-negative early-stage breast cancer
R. Wuerstlein et al.
CURRENT MEDICAL RESEARCH AND OPINION (2016)
Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status
He-Sheng Jiang et al.
ONCOTARGET (2016)
Influence of Androgen Receptor Expression on the Survival Outcomes in Breast Cancer: A Meta-Analysis
Yoonseok Kim et al.
JOURNAL OF BREAST CANCER (2015)
Small studies are more heterogeneous than large ones: a meta-meta-analysis
Joanna IntHout et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2015)
Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo
Valerie N. Barton et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression
Maggie C. U. Cheang et al.
ONCOLOGIST (2015)
Assignment of tumor subtype by genomic testing and pathologic-based approximations: implications on patient's management and therapy selection
A. Romero et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2014)
Complexities of androgen receptor signalling in breast cancer
Keely M. McNamara et al.
ENDOCRINE-RELATED CANCER (2014)
Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis
Francisco E. Vera-Badillo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
Ramesh Narayanan et al.
PLOS ONE (2014)
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide
Dawn R. Cochrane et al.
BREAST CANCER RESEARCH (2014)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
Ayca Gucalp et al.
CLINICAL CANCER RESEARCH (2013)
Androgen receptor-induced tumor suppressor, KLLN, inhibits breast cancer growth and transcriptionally activates p53/p73-mediated apoptosis in breast carcinomas
Yu Wang et al.
HUMAN MOLECULAR GENETICS (2013)
Prognostic Significance of Progesterone Receptor-Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer
Aleix Prat et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement
S. Guiu et al.
ANNALS OF ONCOLOGY (2012)
Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation
Matthew J. Sikora et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity
Francini de Mattos Lima Lin et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
Research Resource: Interplay between the Genomic and Transcriptional Networks of Androgen Receptor and Estrogen Receptor α in Luminal Breast Cancer Cells
Eleanor F. Need et al.
MOLECULAR ENDOCRINOLOGY (2012)
The Androgen Receptor in Breast Tissues: Growth Inhibitor, Tumor Suppressor, Oncogene?
T. E. Hickey et al.
MOLECULAR ENDOCRINOLOGY (2012)
Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers
S. Park et al.
ANNALS OF ONCOLOGY (2011)
Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
Min Ni et al.
CANCER CELL (2011)
Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3β, 17β-diol
Naoko Honma et al.
CANCER SCIENCE (2011)
Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women
Rong Hu et al.
CLINICAL CANCER RESEARCH (2011)
Heterogeneity in breast cancer
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
Laura C. Collins et al.
MODERN PATHOLOGY (2011)
Breast Cancer 2 Gene expression profiling in breast cancer: classification, prognostication, and prediction
Jorge S. Reis-Filho et al.
LANCET (2011)
GOBO: Gene Expression-Based Outcome for Breast Cancer Online
Markus Ringner et al.
PLOS ONE (2011)
A Feedback Loop between Androgen Receptor and ERK Signaling in Estrogen Receptor-Negative Breast Cancer
Kee Ming Chia et al.
NEOPLASIA (2011)
Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers
Isabella Castellano et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Method agreement analysis: A review of correct methodology
P. F. Watson et al.
THERIOGENOLOGY (2010)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors
Elisa J. Cops et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer
Ali Naderi et al.
NEOPLASIA (2008)
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
Lisa A. Carey et al.
CLINICAL CANCER RESEARCH (2007)
The molecular portraits of breast tumors are conserved across microarray platforms
Zhiyuan Hu et al.
BMC GENOMICS (2006)
Steroid receptor regulation of epidermal growth factor signaling through src in breast and prostate cancer cells: Steroid antagonist action
A Migliaccio et al.
CANCER RESEARCH (2005)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
